Technical Analysis for IXI - Ixico Plc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 51.0 | 6.25% | 3.00 |
Earnings due: Dec 6
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical IXI trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jack-in-the-Box Bearish | Bearish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 6.25% | |
| Expansion Breakdown | Bearish Swing Setup | 6.25% | |
| New 52 Week Low | Weakness | 6.25% | |
| Multiple of Ten Bearish | Other | 6.25% | |
| Wide Bands | Range Expansion | 6.25% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 2x Volume Pace | 2 days ago |
| 1.5x Volume Pace | 2 days ago |
| Boomer Sell Entry | 2 days ago |
| Non-ADX 1,2,3,4 Bearish Retracement Entry | 2 days ago |
| 1,2,3, Bearish Retracement Entry | 2 days ago |
Free Daily (Stock) Chart Reading
Ixico Plc Description
IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa, mehealth, MyBrainBook and TrialTracker. Assessa is a decision-support tool for healthcare professionals looking to diagnose dementia and detect the underlying causes. mehealth is an online software for clinicians at the point-of-care to support decision making and improve the monitoring and treatment of patients. MyBrainBook is a digital platform to improve the quality of life and service delivery for people living with dementia and their supporters. TrialTracker is a Web-based system that allows users to track their imaging-based research study or clinical trial in real time. It is also collaborating with partners to develop companion digital health products.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Healthcare Software Pharmaceutical Quality Medicine Clinic Disease Monitoring Clinical Trial Imaging Rtt Eim Healthcare Professionals Mental Health Health Products Pharmaceutical Companies Alzheimer's Disease Dementia Aging Associated Diseases Learning Disabilities Parkinson's Disease Psychiatric Diagnosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 115.0 |
| 52 Week Low | 48.0 |
| Average Volume | 54,801 |
| 200-Day Moving Average | 78.35 |
| 50-Day Moving Average | 69.76 |
| 20-Day Moving Average | 59.85 |
| 10-Day Moving Average | 52.75 |
| Average True Range | 3.29 |
| ADX | 43.81 |
| +DI | 5.80 |
| -DI | 35.95 |
| Chandelier Exit (Long, 3 ATRs) | 61.02 |
| Chandelier Exit (Short, 3 ATRs) | 57.88 |
| Upper Bollinger Bands | 75.26 |
| Lower Bollinger Band | 44.44 |
| Percent B (%b) | 0.21 |
| BandWidth | 51.49 |
| MACD Line | -5.85 |
| MACD Signal Line | -5.25 |
| MACD Histogram | -0.6032 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 52.73 | ||||
| Resistance 3 (R3) | 52.67 | 52.03 | 52.44 | ||
| Resistance 2 (R2) | 52.03 | 51.59 | 52.06 | 52.34 | |
| Resistance 1 (R1) | 51.52 | 51.32 | 51.20 | 51.58 | 52.25 |
| Pivot Point | 50.88 | 50.88 | 50.73 | 50.91 | 50.88 |
| Support 1 (S1) | 50.37 | 50.44 | 50.05 | 50.43 | 49.75 |
| Support 2 (S2) | 49.73 | 50.17 | 49.76 | 49.66 | |
| Support 3 (S3) | 49.22 | 49.73 | 49.56 | ||
| Support 4 (S4) | 49.28 |
